HUMAN ALBUMIN 5% (CSL Behring) price in UAE

Overview

Welcome to Dwaey, specifically on HUMAN ALBUMIN 5% (CSL Behring) Infusion/Solution for page.
This medicine contains an important and useful components, as it consists of Albumin (human).
HUMAN ALBUMIN 5% (CSL Behring) is available in the market in concentration 50mg/ml and in the form of Infusion/Solution for.

CSL BEHRING AG is the producer of HUMAN ALBUMIN 5% (CSL Behring) and it is imported from SWITZERLAND, The most popular alternatives of HUMAN ALBUMIN 5% (CSL Behring) are listed downward .

Mode Of Action

Human albumin increases intravascular oncotic pressure and causes movement of fluids from interstitial into intravascular space. Human albumin solutions are available in various concentrations. Solutions containing 5% human albumin are usually used in hypovolemic patients, whereas more concentrated 25% solutions are recommended in patients in whom fluid and sodium intake must be minimised e.g. patients with hypoproteinaemia or cerebral oedema or in paediatric patients.

Indication

Acute hypovolaemic shock
Hypoproteinaemia

Precaution

Hypertension or low cardiac reserve; additional fluids for dehydrated patients. Monitor for signs of cardiac overload in injured or postoperative patients. May carry risk of viral transmission. Volume admin and rate of infusion must always be individualised according to situation and response. Pregnancy, lactation. Lactation: Endogenous albumin found in breast milk; compatible

Side Effects

Allergic reactions
nausea
vomiting
increased salivation
fever and chills; vascular overload
haemodilution and pulmonary oedema. Potentially Fatal: Anaphylactic shock.

Contra indication

Cardiac failure, severe anaemia, history of hypersensitivity, parenteral nutrition.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Albumin solution should not be mixed by protein hydrolysates or alcoholic solutions. Risk of atypical reactions to ACE inhibitors in patients undergoing therapeutic plasma exchange with albumin human replacement.